However, the more aggressive mouse Pax5Jak2/+ tumor model allowed us to identify the Pax5‐Jak2 protein as an important oncogenic driver of leukemia development, which might have been more difficult to demonstrate in the presence of the competing full‐length Pax5 protein. Here, JAK2 is linked to leukemia.